Insiders · RXDX

Mark Stenhouse

Officer at Prometheus Biosciences, Inc. (RXDX)

Mark Stenhouse has filed 11 insider reports with the SEC since May 2021, as director at Phathom Pharmaceuticals, Inc. (PHAT) and officer at Prometheus Biosciences, Inc. (RXDX). The latest filing, on May 21, 2026, reports grant or award at Phathom Pharmaceuticals, Inc. (PHAT).

Filings
11
Companies
2
Bought on market
None
Sold on market
None

Companies where Mark Stenhouse is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Phathom Pharmaceuticals, Inc. logo
PHAT
Phathom Pharmaceuticals, Inc.
Director54,122$4.66May 21, 2026
Prometheus Biosciences, Inc. logo
RXDX
Prometheus Biosciences, Inc.
Officer0Jun 16, 2023

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Mark Stenhouse with

Other insiders at the same companies

Questions about Mark Stenhouse

What is Mark Stenhouse's role at Prometheus Biosciences, Inc.?
Mark Stenhouse reports to the SEC as officer at Prometheus Biosciences, Inc. (RXDX), according to the latest filing on June 16, 2023. Mark Stenhouse has also filed as director at Phathom Pharmaceuticals, Inc. (PHAT).
How many shares does Mark Stenhouse own?
After the latest filing that states it, Mark Stenhouse directly owned 54,122 shares of Phathom Pharmaceuticals, Inc. (PHAT). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Mark Stenhouse bought or sold stock recently?
No open-market purchases or sales by Mark Stenhouse are on file. The filings report grant or award, sale back to the company and other acquisition or disposition.
How do I get alerts when Mark Stenhouse files?
Follow Mark Stenhouse on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Mark Stenhouse (SEC CIK 0001734751). Totals count each trade once, skipping amendments whose original is on file, from May 24, 2021 on. View on SEC EDGAR · Get this as JSON